The genomic landscape of CYP2D6 variation in the Indian population

被引:0
|
作者
Sivadas, Ambily [1 ]
Rathore, Surabhi [2 ,3 ]
Sahana, S. [2 ,3 ]
Jolly, Bani [2 ,3 ]
Bhoyar, Rahul C. [2 ]
Jain, Abhinav [2 ,3 ]
Sharma, Disha [2 ]
Imran, Mohamed [2 ,3 ]
Senthilvel, Vigneshwar [2 ,3 ]
Divakar, Mohit Kumar [2 ,3 ]
Mishra, Anushree [2 ,3 ]
Sivasubbu, Sridhar [2 ,3 ,4 ]
Scaria, Vinod [2 ,3 ,4 ]
机构
[1] St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India
[2] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110025, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India
[4] Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India
关键词
cytochrome P450; drug metabolism; genomics; Indian population; molecular dynamics simulation; personalized medicine; pharmacogenomics; pharmacology; polymorphism; DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS; CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS; IDENTIFICATION; FREQUENCY;
D O I
10.2217/pgs-2023-0233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles (*86, *7, *111, *112, *113, *99) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 50 条
  • [31] PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting
    Turner, Amy J.
    Nofziger, Charity
    Ramey, Bronwyn E.
    Ly, Reynold C.
    Bousman, Chad A.
    Agundez, Jose A. G.
    Sangkuhl, Katrin
    Whirl-Carrillo, Michelle
    Vanoni, Simone
    Dunnenberger, Henry M.
    Ruano, Gualberto
    Kennedy, Martin A.
    Phillips, Michael S.
    Hachad, Houda
    Klein, Teri E.
    Moyer, Ann M.
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1220 - 1237
  • [32] GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population
    Bank, Paul C. D.
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    van der Straaten, Tahar
    PHARMACOGENOMICS, 2015, 16 (07) : 681 - 687
  • [33] Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine
    Xu, Ren-ai
    Gu, Er-min
    Zhou, Quan
    Yuan, Lingjing
    Hu, Xiaoxia
    Cai, Jianping
    Hu, Guoxin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 687 - 696
  • [34] Effects of 24 CYP2D6 variants found in Chinese population on the metabolism of clonidine in vitro
    Li, Xiang-yu
    Hu, Xiao-xia
    Yang, Fang
    Yuan, Ling-jing
    Cai, Jian-ping
    Hu, Guo-xin
    CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 313
  • [35] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [36] Genetic polymorphisms analysis of CYP2D6 in the Uygur population
    Xue He
    Na He
    Lisong Ren
    Yongri Ouyang
    Ning Zhang
    Yini Ma
    Dongya Yuan
    Longli Kang
    Tianbo Jin
    BMC Genomics, 17
  • [37] Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population
    Ahmed, Shabbir
    Zhou, Jie
    Zhou, Zhan
    Chen, Shu-Qing
    GENES, 2018, 9 (10)
  • [38] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
  • [39] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
  • [40] Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay
    Chen, B.
    Xu, Y.
    Jiang, T.
    Feng, R.
    Sun, J.
    Zhang, W.
    Yang, W.
    Li, J.
    Adeniyi, O.
    Chen, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (06) : 504 - 511